M&T Bank
UTHR icon

M&T Bank’s United Therapeutics UTHR Stock Holding History

M&T Bank’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Sell
2,500
-526
-17% -$296K ﹤0.01% 774
2026
Q1 		$1.79M Sell
3,026
-116
-4% -$57.8K 0.01% 637
2025
Q4 		$1.53M Buy
3,142
+1,985
+172% +$924K ﹤0.01% 725
2025
Q3 		$486K Sell
1,157
-407
-26% -$137K ﹤0.01% 997
2025
Q2 		$450K Sell
1,564
-900
-37% -$269K ﹤0.01% 1114
2025
Q1 		$760K Sell
2,464
-965
-28% -$331K ﹤0.01% 916
2024
Q4 		$1.21M Buy
3,429
+294
+9% +$108K ﹤0.01% 834
2024
Q3 		$1.12M Sell
3,135
-59
-2% -$19.9K ﹤0.01% 859
2024
Q2 		$1.02M Sell
3,194
-17
-0.5% -$4.5K ﹤0.01% 860
2024
Q1 		$737K Sell
3,211
-582
-15% -$131K ﹤0.01% 986
2023
Q4 		$834K Buy
3,793
+17
+0.5% +$3.92K ﹤0.01% 940
2023
Q3 		$853K Sell
3,776
-53
-1% -$12.2K ﹤0.01% 895
2023
Q2 		$846K Buy
3,829
+66
+2% +$14.6K ﹤0.01% 926
2023
Q1 		$842K Buy
3,763
+100
+3% +$24.7K ﹤0.01% 924
2022
Q4 		$1.02M Buy
3,663
+1,336
+57% +$337K ﹤0.01% 849
2022
Q3 		$488K Sell
2,327
-1,490
-39% -$333K ﹤0.01% 1096
2022
Q2 		$402K Buy
3,817
+2,489
+187% +$506K ﹤0.01% 1090
2022
Q1 		$239K Buy
1,328
+55
+4% +$10.5K ﹤0.01% 1309
2021
Q4 		$274K Buy
1,273
+27
+2% +$5.3K ﹤0.01% 1284
2021
Q3 		$230K Hold
1,246
– – ﹤0.01% 1372
2021
Q2 		$223K Sell
1,246
-5
-0.4% -$952 ﹤0.01% 1415
2021
Q1 		$209K Sell
1,251
-143
-10% -$23.8K ﹤0.01% 1408
2020
Q4 		$212K Buy
+1,394
New +$183K ﹤0.01% 1494
2020
Q3 		– Sell
-1,962
Closed -$238K – 1660
2020
Q2 		$238K Sell
1,962
-255
-12% -$28.7K ﹤0.01% 1303
2020
Q1 		$210K Sell
2,217
-357
-14% -$33.9K ﹤0.01% 1307
2019
Q4 		$227K Buy
+2,574
New +$226K ﹤0.01% 1215
2019
Q2 		– Sell
-2,045
Closed -$240K – 1683
2019
Q1 		$240K Sell
2,045
-93
-4% -$10.8K ﹤0.01% 1310
2018
Q4 		$233K Buy
2,138
+40
+2% +$4.64K ﹤0.01% 1225
2018
Q3 		$269K Buy
2,098
+70
+3% +$8.66K ﹤0.01% 1283
2018
Q2 		$231K Buy
2,028
+14
+0.7% +$1.54K ﹤0.01% 1362
2018
Q1 		$225K Sell
2,014
-224
-10% -$28.5K ﹤0.01% 1381
2017
Q4 		$332K Hold
2,238
– – ﹤0.01% 1197
2017
Q3 		$262K Buy
2,238
+21
+0.9% +$2.68K ﹤0.01% 1294
2017
Q2 		$288K Buy
2,217
+179
+9% +$22.3K ﹤0.01% 1222
2017
Q1 		$276K Sell
2,038
-1,879
-48% -$285K ﹤0.01% 1279
2016
Q4 		$562K Sell
3,917
-446
-10% -$56.9K ﹤0.01% 1009
2016
Q3 		$516K Sell
4,363
-1,521
-26% -$183K ﹤0.01% 1038
2016
Q2 		$623K Buy
5,884
+358
+6% +$39.9K ﹤0.01% 945
2016
Q1 		$615K Sell
5,526
-494
-8% -$62.5K ﹤0.01% 965
2015
Q4 		$943K Sell
6,020
-556
-8% -$80.9K 0.01% 816
2015
Q3 		$863K Sell
6,576
-3,510
-35% -$563K 0.01% 867
2015
Q2 		$1.75M Sell
10,086
-4,776
-32% -$859K 0.01% 666
2015
Q1 		$2.56M Buy
14,862
+1,401
+10% +$214K 0.02% 548
2014
Q4 		$1.74M Buy
13,461
+1,434
+12% +$185K 0.01% 650
2014
Q3 		$1.55M Buy
+12,027
New +$1.24M 0.01% 706

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

M&T Bank's UTHR Position: Q2 2026 in Review

M&T Bank reduced its United Therapeutics (UTHR) stake by 17% in Q2 2026, selling an estimated $296K and leaving 2,500 shares worth $1.35M. The position accounts for ﹤0.01% of the portfolio, ranked #774.

M&T Bank first reported a position in UTHR in Q3 2014 and has held it in 45 quarters since. The position peaked at $2.56M in Q1 2015. 875 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • M&T Bank held 2,500 shares of United Therapeutics worth $1.35M as of Q2 2026.
  • M&T Bank sold 526 United Therapeutics shares in Q2 2026, an estimated $296K.
  • United Therapeutics made up ﹤0.01% of M&T Bank's portfolio in Q2 2026, its #774 holding.
  • M&T Bank first reported a position in United Therapeutics in Q3 2014 and has held it in 45 quarters since.
  • M&T Bank's United Therapeutics position peaked at $2.56M in Q1 2015.
  • 875 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.